ESC Premium Access

The impact of diabetes mellitus newly diagnosed by glycated hemoglobin on outcomes in patients undergoing percutaneous coronary intervention- five years prospective follow up study

Congress Presentation

About the speaker

Doctor Muhammad Abu Tailakh

Ben-Gurion University of the Negev, Beer Sheva (Israel)
0 follower

14 more presentations in this session

Sub-optimal anti-diabetic treatment in patients with pre-existing and newly diagnosed diabetes admitted for acute myocardial infarction. A study from the FAST-MI 2015 registry.

Speaker: Professor F. Schiele (Besancon, FR)

Thumbnail

The effect of DPP-4i, GLP-1RA, SGLT-2i and long-acting insulin on platelet function in patients with type 2 diabetes mellitus

Speaker: Doctor A. Antonopoulos (Athens, GR)

Thumbnail

Sex-based differences in cardioprotective role of SGLT-2 inhibitors in patients with type 2 diabetes mellitus

Speaker: Assistant Professor B. Parapid (Belgrade, RS)

Thumbnail

Differential effects of novel antidiabetics on arterial stiffness in patients with type 2 diabetes mellitus

Speaker: Doctor A. Antonopoulos (Athens, GR)

Thumbnail

SGLT2 inhibitors in diabetes with CKD

Speaker: Assistant Professor A. Malik (Valhalla, US)

Thumbnail

Access the full session

Poster Session 3 - Diabetes

Speakers: Doctor M. Abu Tailakh, Professor F. Schiele, Doctor A. Antonopoulos, Assistant Professor B. Parapid, Doctor A. Antonopoulos...
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb